Hot Features
Premium
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Period:
Draw Mode:
| Volume | 124,494 |
|
|||||
| News | - | ||||||
| Day High | 1.6193 | Low High |
|||||
| Day Low | 1.44 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Corvus Pharmaceuticals Inc | CRVS | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.03 | -2.03% | 1.45 | 23:00:04 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 1.56 | 1.44 | 1.6193 | 1.45 | 1.48 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 526 | 124,494 | US$ 1.52 | US$ 189,746 | - | 0.9802 - 4.19 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 17:44:58 | formt | 200 | US$ 1.45 | USD |
Corvus Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 71.11M | 49.04M | - | 0 | -27.03M | -0.55 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Corvus Pharmaceuticals News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CRVS Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.40 | 1.6193 | 1.36 | 1.48 | 96,724 | 0.05 | 3.57% |
| 1 Month | 1.78 | 1.9378 | 1.30 | 1.61 | 150,058 | -0.33 | -18.54% |
| 3 Months | 2.08 | 2.58 | 1.30 | 1.98 | 207,474 | -0.63 | -30.29% |
| 6 Months | 1.16 | 2.58 | 1.05 | 1.81 | 215,849 | 0.29 | 25.00% |
| 1 Year | 0.99 | 4.19 | 0.9802 | 2.31 | 448,375 | 0.46 | 46.46% |
| 3 Years | 2.83 | 9.54 | 0.607 | 4.85 | 1,000,638 | -1.38 | -48.76% |
| 5 Years | 4.31 | 9.54 | 0.607 | 4.72 | 841,077 | -2.86 | -66.36% |
Corvus Pharmaceuticals Description
| Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical engaged in developing drugs and antibodies that target the most critical cellular elements of the immune system. It focuses on the development of immune modulator product candidates to treat COVID-19, T-cell lymphomas, other cancers and autoimmune diseases. The company's lead product candidate is CPI-006 which is a potent humanized monoclonal antibody that is designed to react with a specific site on CD73. Its other product candidates are CPI-818, CPI-935, CPI-182 and Ciforadenant. |
